Norges Bank’s KALA BIO KALA Stock Holding History

Norges Bank’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-37	Closed	-$1.45M	–	2150
2018 Q1	$1.45M	Hold	37	–	–	﹤0.01%	2035
2017 Q4	$1.7M	Buy	37 +23	+164%	+$1.08M	﹤0.01%	1996
2017 Q3	$799K	Buy	+14	New	+$768K	﹤0.01%	2083

Other funds holding KALA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank's KALA Position: Q2 2018 in Review

Norges Bank sold out of KALA BIO (KALA) in Q2 2018, closing a stake of 37 shares — an estimated $1.45M sold.

Norges Bank first reported a position in KALA in Q3 2017 and held it in 3 quarters. The position peaked at $1.7M in Q4 2017. 54 funds tracked by Wall St. Rank hold KALA as of Q2 2018.

Norges Bank reported no remaining KALA BIO position as of Q2 2018 after selling out during the quarter.
Norges Bank sold 37 KALA BIO shares in Q2 2018, an estimated $1.45M.
Norges Bank first reported a position in KALA BIO in Q3 2017 and held it in 3 quarters.
Norges Bank's KALA BIO position peaked at $1.7M in Q4 2017.
54 funds tracked by Wall St. Rank held KALA BIO as of Q2 2018.

Based on Norges Bank's 13F filing for Q2 2018, filed 23 Jul 2018.